Dark
Streaming/Mobile
Old Site
Home
Products
Help
Contact Us
Your Account
System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
16:06:31 EDT Thu 28 Mar 2024
Quotes
Streaming/Mobile
Quick Quotes (x20)
Symbol Search
Company Search
Market Depth
US Options
Montreal Options
Foreign Exchange
Download Close Prices
Short History
Quotes Help
Charts
12 Month Chart
Advanced Chart
Live Intraday Chart
Live Historical Chart
Live Java Intraday Chart
Live Java Historical Chart
Charts Help
News
News Search
SEDAR Search
SEDAR Alerts
News Help
Indexes
Major Indexes
US incl Dow Jones
NASDAQ
S&P CME
PBOT - Phil Ex
TSX - Toronto
TSX-V - TSX Venture
Indexes Help
Portfolio
View Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Value Portfolio
All Portfolios
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Edit Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Chart Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Live Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
View Portfolio News
Daily Summary
Portfolio Help
Analytics
Exchange Statistics
Most Active
Live Most Active
Block Trades
Broker Trades
Halted Stocks
Dividends
Participants
Companies
Trade Workstation
Company Picker
Short Positions
Broker Codes
Analytics Help
Mutual Funds
Mutual Fund Search
Targeted Holder Search
SEDAR Fund Search
Mutual Fund Help
Enter Symbol
or Name
USA
CA
Quote
Chart
News
Closes
Depth
Forgot password?
Trouble logging in?
Login to Stockwatch
News for U:IBIO from 2023-03-29 to 2024-03-28 - 19 items
News Releases
In The News
Other
CA
US
Date
Sym
Price
Type
Headline
2024-03-27 07:00
U
U:IBIO
News Release
200
iBio and AstralBio Announce Transformative AI drug discovery Collaboration to Rapidly Develop Novel Antibodies for Obesity and Cardiometabolic Diseases
2024-03-26 19:35
U
U:IBIO
News Release
200
iBio Announces $15.0 Million Private Placement
2024-02-26 07:45
U
U:IBIO
News Release
200
iBio Announces Sale of Preclinical PD-1 Agonist Antibody Program to Otsuka
2024-01-16 08:15
U
U:IBIO
News Release
200
iBio Announces Participation in 23rd Annual PepTalk Conference
2023-12-26 07:15
U
U:IBIO
News Release
200
iBio Amends and Extends Maturity of Credit Agreement
2023-12-05 08:00
U
U:IBIO
News Release
200
iBio, Inc. Announces Pricing of $4.5 Million Public Offering
2023-11-27 17:20
U
U:IBIO
News Release
200
iBio Announces Reverse Stock Split
2023-11-01 08:24
U
U:IBIO
News Release
200
iBio Further Expands Tech Stack with ShieldTx ¢ „ ¢; Enhances Immuno-Oncology ‚ Development Pipeline with Conditionally Activated MUC16xCD3 Bispecific
2023-10-10 08:00
U
U:IBIO
News Release
200
iBio to Highlight Technology for Advancing Discovery of Bispecifics at Festival of Biologics
2023-10-02 06:45
U
U:IBIO
News Release
200
iBio Explains Recent Filing of Registration Statement
2023-09-27 16:19
U
U:IBIO
News Release
200
iBio Announces Filing of 2023 Annual Report on SEC Form 10-K
2023-09-21 16:05
U
U:IBIO
News Release
200
iBio Announces Amendment to Credit Agreement with Woodforest
2023-08-14 16:15
U
U:IBIO
News Release
200
iBio Reports Triple Milestone: In Vivo Proof-of-Concept for Three Programs, a Transformative Step in Advancing its Immuno-Oncology Pre-Clinical Pipeline Towards Clinical Development
2023-06-27 08:00
U
U:IBIO
News Release
200
iBio Appoints Dr. Martin Brenner as CEO, Felipe Duran as CFO to Oversee Company ¢ € ™s Next Stage of Growth
2023-06-12 16:15
U
U:IBIO
News Release
200
iBio Forges Research Collaboration with the National Institutes of Health
2023-06-06 08:00
U
U:IBIO
News Release
200
iBio Expands Tech Stack with EngageTx ¢ „ ¢; Adds TROP-2 Bispecific to Development Pipeline
2023-05-09 16:30
U
U:IBIO
News Release
200
iBio to Participate in the JMP Securities Life Sciences Conference
2023-04-04 16:05
U
U:IBIO
News Release
200
iBio Discovers New Panel of CD3 T-Cell Binding Antibodies Using its Patented AI Epitope Steering Platform
2023-03-31 08:10
U
U:IBIO
News Release
200
iBio Advances Anti-CCR8 Antibody Program to Preclinical In Vivo Testing